Drug Repositioning and Repurposing for Disease-Modifying Effects in Parkinson's Disease.

J Mov Disord · 2025 · PMC12061612 · PMID 39914809

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the results did not reach statistical significance [ 91 ].

also in 111,027 other papers

a nonsignificant trendno p-value reported

The SKY study, which included patients with early-stage PD receiving stable dopaminergic therapy, revealed no significant benefit of deferiprone in improving motor symptoms, except for a nonsignificant trend toward improvement at a dose of 600 mg twice daily.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.